Home › Funds › Pivotal bioVenture Partners Investment Advisor LLC › RLYB

Pivotal bioVenture Partners Investment Advisor LLC position in RLYB

RALLYBIO CORP · Health Care

Pivotal bioVenture Partners Investment Advisor LLC reported holding 300,579 shares of RLYB (RALLYBIO CORP) in its Q3 2026 13F filing — a position valued at US$5.2M, representing 2.11% of its reported portfolio and ranking #12 among its reported holdings. Pivotal bioVenture Partners Investment Advisor LLC has disclosed RLYB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)300.58K sh
Reported value held$5.17M
Portfolio Weight2.11%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Pivotal bioVenture Partners Investment Advisor LLC's RLYB position evolved

Pivotal bioVenture Partners Investment Advisor LLC first disclosed a stake in RLYB in Q3 2023 at 2,404,644 shares (US$8.1M). Across 13 filings, Pivotal bioVenture Partners Investment Advisor LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 300,579 shares valued at US$5.2M. Notable position changes include a 88% trim in Q1 2026 (shares rose 78% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.40M $8.10M New
Q4 2023 2.40M $5.75M Hold
Q1 2024 2.40M $4.45M Hold
Q2 2024 2.40M $3.22M Hold
Q3 2024 2.40M $2.81M Hold
Q4 2024 2.40M $2.31M Hold
Q1 2025 2.40M $1.56M Hold
Q2 2025 2.40M $812.77K Hold
Q3 2025 2.40M $1.20M Hold
Q4 2025 2.40M $1.65M Hold
Q1 2026 300.58K $2.70M Reduce
Q2 2026 300.58K $4.81M Hold
Q3 2026 300.58K $5.17M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RLYB and 13F data

RLYB (RALLYBIO CORP) is a Health Care company. 24 other funds we track also report a position in RLYB — the largest reported positions include ADAR1 Capital Management, LLC (US$14.8M), TPG GP A, LLC (US$6.1M), Almitas Capital LLC (US$1.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RLYB

All RLYB fund holders →

FAQ

How long has Pivotal bioVenture Partners Investment Advisor LLC held RLYB?

Pivotal bioVenture Partners Investment Advisor LLC has disclosed RLYB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Pivotal bioVenture Partners Investment Advisor LLC's current position in RLYB?

As of Q3 2026, Pivotal bioVenture Partners Investment Advisor LLC holds 300.58K shares of RLYB (RALLYBIO CORP), valued at $5.17M, representing 2.11% of its reported portfolio and ranking #12.

Has Pivotal bioVenture Partners Investment Advisor LLC been buying or selling RLYB?

In the latest 13F filing (Q3 2026), Pivotal bioVenture Partners Investment Advisor LLC held unchanged its position in RLYB.

Which other funds hold RLYB?

Other major institutional holders of RLYB include ADAR1 Capital Management, LLC, TPG GP A, LLC, Almitas Capital LLC, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.